e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met
R. Brauer (Los Angeles, United States of America)
Source:
Lung Science Conference 2015
Number:
20
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Brauer (Los Angeles, United States of America). Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met. Lung Science Conference 2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Targeted immunomodulation in airway epithelium to treat pneumonia
Definition and history of sarcoidosis
Clinical case discussion: How clinical trials inform antibiotic stewardship
Related content which might interest you:
c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
ASK1 regulates influenza virus infection-induced apoptotic cell death
Source: Eur Respir J 2003; 22: Suppl. 45, 456s
Year: 2003
miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung
Source: Eur Respir J, 58 (3) 1901789; 10.1183/13993003.01789-2019
Year: 2021
Syk mediates BEAS-2B cell migration and proliferation in response to injury and HRV infection
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Febrile-range hyperthermia augments lung injury through a mechanism involving death receptor signaling
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
The NS1A binding protein in alveolar epithelial cells as centerpiece of Influenza virus A lung injury mechanism mediated via AhR/Arnt signaling pathway
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Inhibition of neutrophil apoptosis by sphingosin-1-phopsphate through the activation of neutral sphingomyelinase in acute lung injury
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 101s
Year: 2005
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Inhibition of VEGF blocks the activation of TGF-β
1
through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Nontypeable Haemophilus influenzae-promoted proliferation of K-ras-induced early lung cancer lesions is completely dependent on Toll-like receptor signaling
Source: ERS Lung Science Conference 2017
Year: 2017
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept